Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Effect of Single Dose NP001 on Blood Markers of Inflammation in Individuals With Mild-to-Moderate Alzheimer's Disease

Authors not listed

Beau Nakamoto · 2017

Abstract

This is a Phase 1 placebo-controlled biomarker study of NP001 in individuals with Alzheimer's Disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Anonymous. (2017). Effect of Single Dose NP001 on Blood Markers of Inflammation in Individuals With Mild-to-Moderate Alzheimer's Disease. <em>Beau Nakamoto</em>. https://clinicaltrials.gov/study/NCT03179501
Vancouver
Anonymous. Effect of Single Dose NP001 on Blood Markers of Inflammation in Individuals With Mild-to-Moderate Alzheimer's Disease. Beau Nakamoto. 2017.
BibTeX
@misc{anon2017Effect, title = {Effect of Single Dose NP001 on Blood Markers of Inflammation in Individuals With Mild-to-Moderate Alzheimer's Disease}, author = {Anonymous}, journal = {Beau Nakamoto}, year = {2017}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings